Snowden Capital Advisors LLC Immunocore Holdings PLC Transaction History
Snowden Capital Advisors LLC
- $3.5 Billion
- Q3 2025
A detailed history of Snowden Capital Advisors LLC transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Snowden Capital Advisors LLC holds 7,548 shares of IMCR stock, worth $271,350. This represents 0.01% of its overall portfolio holdings.
Number of Shares
7,548
Previous 7,674
1.64%
Holding current value
$271,350
Previous $240,000
14.17%
% of portfolio
0.01%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding IMCR
# of Institutions
146Shares Held
46.9MCall Options Held
325KPut Options Held
1.74M-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.06MShares$254 Million0.16% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$175 Million2.36% of portfolio
-
Wellington Management Group LLP Boston, MA4.78MShares$172 Million0.03% of portfolio
-
Primecap Management CO Pasadena, CA3.75MShares$135 Million0.11% of portfolio
-
Bellevue Group Ag Kuesnacht, V82.8MShares$101 Million2.17% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.58B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...